Top compounds associated with response to MYO1F


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA GSK690693 GDSC1000 pan-cancer AAC -0.14 0.0001
mRNA TG-101348 CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA AZD7762 CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA AP-24534 GDSC1000 pan-cancer AAC 0.14 0.0002
mRNA barasertib CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA GDC-0879 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA ATRA FIMM pan-cancer AAC 1 0.0002
mRNA Crizotinib CCLE pan-cancer AAC 0.18 0.0002
Download CSV